Joseph M Leone
CIK 1176381 · Vice Chairman and CFO · last filed 2017-07-05
Joseph M Leone is a Vice Chairman and CFO who has filed 35 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ALQA, was dated Jul 5, 2017. Across all open-market trades the lifetime net is −$9.5M, making them a net seller over the disclosed history. 43 SEC filings were submitted jointly with CIT GROUP INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CIT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Alliqua BioMedical, Inc. (ALQA) Delisted | Director | 7,304 | — | — | $19.7K | 6 | 2017-07-05 |
| CIT GROUP INC (CIT) Delisted | Vice Chairman and CFO | 3,380 | $53.50 | $180.9K | -$9.51M | 22 | 2010-04-29 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-05 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-04 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +25,000 | $10.0K | EDGAR |
| 2016-05-13 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-09 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +3,500 | $9.7K | EDGAR |
| 2015-05-08 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-07-02 | — | Mixed | +123,457 | $0 | |
| 2013-02-26 | — | Mixed | +246,914 | $0 | |
| 2013-02-26 | — | Grant (A) | — | $0 | |
| 2013-02-26 | — | Buy (P) | +300,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.